COMMUNIQUÉS West-GlobeNewswire

-
BioAtla to Announce First Quarter 2024 Financial Results and Provide Business Highlights on May 14, 2024
07/05/2024 -
Sagimet Announces Oral Presentation of Data from the Phase 2b FASCINATE-2 Study of Denifanstat in MASH at EASL International Liver Congress 2024
07/05/2024 -
Erasca to Present at the Bank of America Health Care Conference
07/05/2024 -
Apnimed Named 2024 Best Places to Work Company by the Boston Business Journal
07/05/2024 -
Sirona Biochem Engages Stonegate Healthcare Partners
07/05/2024 -
Windtree Therapeutics Regains Compliance with Nasdaq
07/05/2024 -
RadNet’s Lenox Hill Radiology to Host Mother’s Day Mammogram Screening Parties in New York City
07/05/2024 -
Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment
07/05/2024 -
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
07/05/2024 -
Lexeo Therapeutics to Participate in Upcoming Investor Conferences
07/05/2024 -
Arbutus to Participate in Two Upcoming Investor Conferences
07/05/2024 -
Altimmune to Participate at Two Upcoming Investor Conferences
07/05/2024 -
Enable Injections Expands Strategic Partnership with Roche
07/05/2024 -
ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer
07/05/2024 -
Coloplast Finance B.V. - Interim Financial Report, H1 2023/24
07/05/2024 -
EyeDNA Therapeutics Announces Positive 24-month Data Presented at ARVO from Ongoing Phase I/II Trial of HORA-PDE6b Gene Therapy in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b
07/05/2024 -
CMR Surgical appoints Shlomi Cohen as Chief Financial Officer
07/05/2024 -
Memo Therapeutics increases Series C financing to CHF 45 million
07/05/2024 -
Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025
07/05/2024
Pages